Ventyx Biosciences Ownership
| VTYX Stock | USD 1.73 0.01 0.58% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Ventyx |
Ventyx Stock Ownership Analysis
About 85.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.44. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Ventyx Biosciences recorded a loss per share of 2.35. The entity had not issued any dividends in recent years. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California. Ventyx Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people. For more information please call Raju Mohan at 760 593 4832 or visit https://ventyxbio.com.Ventyx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ventyx Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ventyx Biosciences backward and forwards among themselves. Ventyx Biosciences' institutional investor refers to the entity that pools money to purchase Ventyx Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.3 M | Opaleye Management Inc | 2024-06-30 | 1.2 M | State Street Corp | 2024-06-30 | 1.2 M | Parkman Healthcare Partners Llc | 2024-06-30 | 1.2 M | Schonfeld Strategic Advisors Llc | 2024-06-30 | 1.2 M | Sphera Funds Management Ltd. | 2024-06-30 | 1 M | Jpmorgan Chase & Co | 2024-06-30 | 987.3 K | Sio Capital Management, Llc | 2024-06-30 | 778.9 K | Walleye Trading Advisors, Llc | 2024-06-30 | 510.8 K | Deerfield Management Co | 2024-06-30 | 5.8 M | Citadel Advisors Llc | 2024-06-30 | 5.8 M |
Ventyx Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ventyx Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ventyx Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ventyx Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ventyx Biosciences Outstanding Bonds
Ventyx Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ventyx Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ventyx bonds can be classified according to their maturity, which is the date when Ventyx Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.